[1] Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Pineda RF, et al. Decreased influenza activity during the COVID-19 pandemic - United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep 2020;69(37):1305 − 9. http://dx.doi.org/10.15585/mmwr.mm6937a6CrossRef
[2] Lee H, Lee H, Song KH, Kim ES, Park JS, Jung J, et al. Impact of public health interventions on seasonal influenza activity during the COVID-19 outbreak in Korea. Clin Infect Dis 2020. http://dx.doi.org/10.1093/cid/ciaa672CrossRef
[3] Soo RJJ, Chiew CJ, Ma S, Pung R, Lee V. Decreased influenza incidence under COVID-19 control measures, Singapore. Emerg Infect Dis 2020;26(8):1933 − 5. http://dx.doi.org/10.3201/eid2608.201229CrossRef
[4] Leuzinger K, Roloff T, Gosert R, Sogaard K, Naegele K, Rentsch K, et al. Epidemiology of severe acute respiratory syndrome coronavirus 2 emergence amidst community-acquired respiratory viruses. J Infect Dis 2020;222(8):1270 − 9. http://dx.doi.org/10.1093/infdis/jiaa464CrossRef
[5] Roser M, Ritchie H, Ortiz-Ospina E, Hasell J. Coronavirus pandemic (COVID-19). Our world in Data. 2020. https://ourworldindata.org/coronavirus. [2020-8-30].https://ourworldindata.org/coronavirus
[6] Q&A: Influenza and COVID-19 - similarities and differences. https://www.who.int/westernpacific/news/q-a-detail/q-a-similarities-and-differences-covid-19-and-influenza. [2020-9-29].https://www.who.int/westernpacific/news/q-a-detail/q-a-similarities-and-differences-covid-19-and-influenza
[7] Biggerstaff M, Cauchemez S, Reed C, Gambhir M, Finelli L. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature. BMC Infect Dis 2014;14:480. http://dx.doi.org/10.1186/1471-2334-14-480CrossRef
[8] Laurie KL, Guarnaccia TA, Carolan LA, Yan AWC, Aban M, Petrie S, et al. Interval between infections and viral hierarchy are determinants of viral interference following influenza virus infection in a ferret model. J Infect Dis 2015;212(11):1701 − 10. http://dx.doi.org/10.1093/infdis/jiv260CrossRef
[9] Schultz-Cherry S. Viral interference: the case of influenza viruses. J Infect Dis 2015;212(11):1690 − 1. http://dx.doi.org/10.1093/infdis/jiv261CrossRef
[10] Greer RM, McErlean P, Arden KE, Faux CE, Nitsche A, Lambert SB, et al. Do rhinoviruses reduce the probability of viral co-detection during acute respiratory tract infections? J Clin Virol 2009;45(1):10 − 5. http://dx.doi.org/10.1016/j.jcv.2009.03.008CrossRef
[11] Nowak MD, Sordillo EM, Gitman MR, Paniz Mondolfi AE. Coinfection in SARS-CoV-2 infected patients: where are influenza virus and rhinovirus/enterovirus? J Med Virol 2020;92(10):1699 − 700. http://dx.doi.org/10.1002/jmv.25953CrossRef
[12] Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 2020;81(2):266 − 75. http://dx.doi.org/10.1016/j.jinf.2020.05.046CrossRef
[13] Huo X, Qin YF, Qi X, Zu RQ, Tang FY, Li L, et al. Surveillance of 16 respiratory viruses in patients with influenza‐like illness in Nanjing, China. J Med Virol 2012;84(12):1980 − 4. http://dx.doi.org/10.1002/jmv.23401CrossRef
[14] Alfaraj SH, Al-Tawfiq JA, Alzahrani NA, Altwaijri TA, Memish ZA. The impact of co-infection of influenza A virus on the severity of Middle East respiratory syndrome coronavirus. J Infect 2017;74(5):521 − 3. http://dx.doi.org/10.1016/j.jinf.2017.02.001CrossRef
[15] de Souza WM, Buss LF, da Silva Candido D, Carrera JP, Li S, Zarebski AE, et al. Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil. Nat Hum Behav 2020;4(8):856 − 65. http://dx.doi.org/10.1038/s41562-020-0928-4CrossRef
[16] Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA 2020;323(20):2085 − 6. http://dx.doi.org/10.1001/jama.2020.6266CrossRef
[17] Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020;323(20):2052 − 9. http://dx.doi.org/10.1001/jama.2020.6775CrossRef
[18] Garcia-Vidal C, Sanjuan G, Moreno-García E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect 2020. http://dx.doi.org/10.1016/j.cmi.2020.07.041CrossRef
[19] Wang M, Wu Q, Xu WZ, Qiao B, Wang JW, Zheng HY, et al. Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan. medRxiv. 2020. https://www.medrxiv.org/content/101101/2020.02.1220022327v2. [2020-10-16].https://www.medrxiv.org/content/101101/2020.02.1220022327v2
[20] Zhu XJ, Ge YY, Wu T, Zhao KC, Chen Y, Wu B, et al. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res 2020;285:198005. http://dx.doi.org/10.1016/j.virusres.2020.198005CrossRef
[21] Ma SM, Lai XQ, Chen Z, Tu SH, Qin K. Clinical characteristics of critically ill patients co-infected with SARS-CoV-2 and the influenza virus in Wuhan, China. Int J Infect Dis 2020;96:683 − 7. http://dx.doi.org/10.1016/j.ijid.2020.05.068CrossRef
[22] Stowe J, Tessier E, Zhao HX, Guy R, Muller-Pebody B, Zambon M, et al. Interactions between SARS-CoV-2 and Influenza and the impact of coinfection on disease severity: a test negative design. medRxiv. 2020. https://www.medrxiv.org/content/10.1101/2020.09.18.20189647v2. [2020-10-16].https://www.medrxiv.org/content/10.1101/2020.09.18.20189647v2
[23] Hui KPY, Cheung MC, Perera RAPM, Ng KC, Bui CHT, Ho JCW, et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir Med 2020;8(7):687 − 95. http://dx.doi.org/10.1016/S2213-2600(20)30193-4CrossRef
[24] Suwanwongse K, Shabarek N. Can coinfection with influenza worsen COVID-19 outcomes? J Investig Med High Impact Case Rep 2020. http://dx.doi.org/10.1177/2324709620953282CrossRef
[25] Hashemi SA, Safamanesh S, Ghasemzadeh‐moghaddam H, Ghafouri M, Azimian A. High prevalence of SARS-CoV-2 and influenza a virus (H1N1) coinfection in dead patients in Northeastern Iran. J Med Virol 2020. http://dx.doi.org/10.1002/jmv.26364CrossRef
[26] Wu P, Lu WR, He L, Meng YF, Wu P, Ding WC, et al. COVID-19 patients with recent influenza A/B infection: a retrospective study. J Infect 2020. http://dx.doi.org/10.1016/j.jinf.2020.05.050CrossRef
[27] Ceccarelli G, d’Ettorre G, Innocenti GP, Mastroianni CM, Ciccozzi M, d’Ettorre G. Is previous influenza-like illness a potential Trojan horse for COVID-19? Crit Care 2020;24(1):503. http://dx.doi.org/10.1186/s13054-020-03226-5CrossRef
[28] WHO. WHO COVID-19 weekly operational update. WHO. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20201005-weekly-epi-update-8.pdf. [2020-10-12].https://www.who.int/docs/default-source/coronaviruse/situation-reports/20201005-weekly-epi-update-8.pdf
[29] Fink G, Orlova-Fink N, Schindler T, Grisi S, Ferrer AP, Daubenberger C, et al. Inactivated trivalent influenza vaccine is associated with lower mortality among COVID-19 patients in Brazil. medRxiv. 2020. https://www.medrxiv.org/content/10.1101/2020.06.29.20142505v1. [2020-10-16].https://www.medrxiv.org/content/10.1101/2020.06.29.20142505v1
[30] Jehi L, Ji X, Milinovich A, Erzurum S, Rubin BP, Gordon S, et al. Individualizing risk Prediction for positive coronavirus disease 2019 testing: results from 11, 672 patients. Chest 2020;158(4):1364 − 75. http://dx.doi.org/10.1016/j.chest.2020.05.580CrossRef
[31] Zanettini C, Omar M, Dinalankara W, Imada EL, Colantuoni E, Parmigiani G, et al. Influenza Vaccination and COVID-19 Mortality in the USA. medRxiv. 2020. https://www.medrxiv.org/content/10.1101/2020.06.24.20129817v1. [2020-10-16].https://www.medrxiv.org/content/10.1101/2020.06.24.20129817v1
[32] Amato M, Werba JP, Frigerio B, Coggi D, Sansaro D, Ravani A, et al. Relationship between influenza vaccination coverage rate and COVID-19 outbreak: an Italian ecological study. Vaccines (Basel) 2020;8(3):535. http://dx.doi.org/10.3390/vaccines8030535CrossRef
[33] Eldanasory OA, Rabaan AA, Al-Tawfiq JA. Can influenza vaccine modify COVID-19 clinical course? Travel Med Infect Dis 2020;37:101872. http://dx.doi.org/10.1016/j.tmaid.2020.101872CrossRef